Skip to main content
Fig. 3 | BMC Immunology

Fig. 3

From: Multiplex array analysis of circulating cytokines and chemokines in COVID-19 patients during the first wave of the SARS-CoV-2 pandemic in Milan, Italy

Fig. 3

Effect of early treatment on IP-10 and IL-6 plasma levels between T0 and T1. A-D) IP-10 levels following treatment with azithromycin (AZ), hydroxychloroquine (HCQ), their combination (AZ + HCQ) and other treatments (Other), respectively. E-H) Variations in IL-6 serum levels post-treatment with AZ, HCQ, their combination and other therapeutic regimens, respectively. Concentrations of IL-6 and IP-10 are provided as log10 (Log) of concentrations (picograms per milliliter, pg/ml). Statistical analyses were performed using paired t test. Statistical significance is indicated above the graphs

Back to article page

BMC Immunology

ISSN: 1471-2172

Contact us